Elixir Pharmaceuticals' Death

Elixir Pharmaceuticals raised a round of funding on September 18, 2013. Investors include Dead.

Elixir Pharmaceuticals a Cambridge MA-based biopharmaceutical company focuses on developing and commercializing drugs to treat and prevent metabolic disease and age-related diseases.…

Articles about Elixir Pharmaceuticals' Death: